dc.contributor.author | Younossi, ZM | en_US |
dc.contributor.author | Stepanova, M | en_US |
dc.contributor.author | Feld, J | en_US |
dc.contributor.author | Zeuzem, S | en_US |
dc.contributor.author | Sulkowski, M | en_US |
dc.contributor.author | Foster, GR | en_US |
dc.contributor.author | Mangia, A | en_US |
dc.contributor.author | Charlton, M | en_US |
dc.contributor.author | O'Leary, JG | en_US |
dc.contributor.author | Curry, MP | en_US |
dc.contributor.author | Nader, F | en_US |
dc.contributor.author | Henry, L | en_US |
dc.contributor.author | Hunt, S | en_US |
dc.date.accessioned | 2017-05-17T11:10:36Z | |
dc.date.available | 2016-10-31 | en_US |
dc.date.issued | 2017-03 | en_US |
dc.date.submitted | 2017-01-04T08:24:27.092Z | |
dc.identifier.issn | 1542-3565 | en_US |
dc.identifier.uri | http://qmro.qmul.ac.uk/xmlui/handle/123456789/23141 | |
dc.description.sponsorship | This study was funded by Gilead Sciences. | en_US |
dc.format.extent | 421 - + | en_US |
dc.relation.ispartof | CLINICAL GASTROENTEROLOGY AND HEPATOLOGY | en_US |
dc.rights | © 2017. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/ | |
dc.subject | PRO | en_US |
dc.subject | Quality of Life | en_US |
dc.subject | Direct-Acting Antivirals | en_US |
dc.subject | DAA | en_US |
dc.title | Sofosbuvir and Velpatasvir Combination Improves Patient-reported Outcomes for Patients With HCV Infection, Without or With Compensated or Decompensated Cirrhosis | en_US |
dc.type | Article | |
dc.rights.holder | © 2017 by the AGA Institute | |
dc.identifier.doi | 10.1016/j.cgh.2016.10.037 | en_US |
pubs.author-url | http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000397246700021&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=612ae0d773dcbdba3046f6df545e9f6a | en_US |
pubs.issue | 3 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published | en_US |
pubs.volume | 15 | en_US |